| Year |
Citation |
Score |
| 2020 |
Korevaar E, Karahalios A, Forbes AB, Turner SL, McDonald S, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Methods used to meta-analyse results from interrupted time series studies: A methodological systematic review protocol. F1000research. 9: 110. PMID 33163155 DOI: 10.12688/F1000Research.22226.1 |
0.375 |
|
| 2020 |
Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, Bero L, Gomes F, Petticrew M, McKee M, Stuckler D, Sacks G. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. Bmj Open. 10: e034082. PMID 32690498 DOI: 10.1136/Bmjopen-2019-034082 |
0.341 |
|
| 2020 |
Turner K, Carboni-Jiménez A, Benea C, Elder K, Levis B, Boruff J, Roseman M, Bero L, Lexchin J, Turner EH, Benedetti A, Thombs BD. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. Bmj Open. 10: e035633. PMID 32398334 DOI: 10.1136/Bmjopen-2019-035633 |
0.364 |
|
| 2020 |
Moynihan R, Fabbri A, Parker L, Bero L. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare. Bmj Open. 10: e034195. PMID 32393611 DOI: 10.1136/Bmjopen-2019-034195 |
0.343 |
|
| 2020 |
Ding D, Nguyen B, Gebel K, Bauman A, Bero L. Duplicate and salami publication: a prevalence study of journal policies. International Journal of Epidemiology. 49: 281-288. PMID 32244256 DOI: 10.1093/Ije/Dyz187 |
0.303 |
|
| 2020 |
Grundy Q, Mazzarello S, Bero L. A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysis. Accountability in Research. PMID 32233796 DOI: 10.1080/08989621.2020.1748015 |
0.311 |
|
| 2020 |
Grundy Q, Dunn AG, Bero L. Improving researchers' conflict of interest declarations. Bmj (Clinical Research Ed.). 368: m422. PMID 32161006 DOI: 10.1136/Bmj.M422 |
0.304 |
|
| 2020 |
Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: A review. Journal of Clinical Epidemiology. PMID 32109503 DOI: 10.1016/J.Jclinepi.2020.02.006 |
0.343 |
|
| 2019 |
Page MJ, Bero L, Kroeger CM, Dai Z, McDonald S, Forbes A, McKenzie JE. Investigation of Risk Of Bias due to Unreported and SelecTively included results in meta-analyses of nutrition research: the ROBUST study protocol. F1000research. 8: 1760. PMID 32117567 DOI: 10.12688/F1000Research.20726.2 |
0.373 |
|
| 2019 |
Grundy Q, Mayes C, Holloway K, Mazzarello S, Thombs BD, Bero L. Conflict of interest as ethical shorthand: Understanding the range and nature of "non-financial conflict of interest" in biomedicine. Journal of Clinical Epidemiology. PMID 31866470 DOI: 10.1016/J.Jclinepi.2019.12.014 |
0.326 |
|
| 2019 |
Johansson M, Bero L, Bonfill X, Bruschettini M, Garner S, Glenton C, Harris R, Jørgensen KJ, Levinson W, Lotfi T, Montori V, Meng DM, Schünemann H, Vaz Carneiro A, Woloshin S, et al. Cochrane Sustainable Healthcare: evidence for action on too much medicine. The Cochrane Database of Systematic Reviews. 12: ED000143. PMID 31808554 DOI: 10.1002/14651858.Ed000143 |
0.309 |
|
| 2019 |
Wang Z, Grundy Q, Parker L, Bero L. Health promoter, advocate, legitimiser - the many roles of WHO guidelines: a qualitative study. Health Research Policy and Systems. 17: 96. PMID 31805956 DOI: 10.1186/S12961-019-0489-Z |
0.375 |
|
| 2019 |
Grundy Q, Chiu K, Bero L. Commercialization of User Data by Developers of Medicines-Related Apps: a Content Analysis. Journal of General Internal Medicine. PMID 31529374 DOI: 10.1007/S11606-019-05214-0 |
0.314 |
|
| 2019 |
Samet JM, Chiu WA, Cogliano V, Jinot J, Kriebel D, Lunn RM, Beland FA, Bero L, Browne P, Fritschi L, Kanno J, Lachenmeier DW, Lan Q, Lasfargues G, Curieux FL, et al. The IARC Monographs: Updated procedures for modern and transparent evidence synthesis in cancer hazard identification. Journal of the National Cancer Institute. PMID 31498409 DOI: 10.1093/Jnci/Djz169 |
0.322 |
|
| 2019 |
McDonald S, Fabbri A, Parker L, Williams J, Bero L. Medical donations are not always free: an assessment of compliance of medicine and medical device donations with World Health Organization guidelines (2009-2017). International Health. PMID 30916303 DOI: 10.1093/Inthealth/Ihz004 |
0.331 |
|
| 2019 |
Moynihan R, Lai A, Jarvis H, Duggan G, Goodrick S, Beller E, Bero L. Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories. Bmj Open. 9: e025864. PMID 30813119 DOI: 10.1136/Bmjopen-2018-025864 |
0.305 |
|
| 2019 |
Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: protocol for a review. Bmj Open. 9: e024096. PMID 30696676 DOI: 10.1136/Bmjopen-2018-024096 |
0.336 |
|
| 2019 |
Hansen C, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. Conflicts of interest and recommendations in clinical guidelines, opinion pieces, and narrative reviews Cochrane Database of Systematic Reviews. 2019. DOI: 10.1002/14651858.Mr000040.Pub2 |
0.329 |
|
| 2019 |
Mintzes B, Fabbri A, Grundy Q, Spurling GKP, Lexchin J, McKenzie JE, Bero L. Information and promotional strategies by pharmaceutical companies for clinicians Cochrane Database of Systematic Reviews. 2019. DOI: 10.1002/14651858.Cd013423.Pub2 |
0.337 |
|
| 2018 |
Bero L, Chartres N, Diong J, Fabbri A, Ghersi D, Lam J, Lau A, McDonald S, Mintzes B, Sutton P, Turton JL, Woodruff TJ. The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures. Systematic Reviews. 7: 242. PMID 30577874 DOI: 10.1186/S13643-018-0915-2 |
0.323 |
|
| 2018 |
Rasmussen K, Bero L, Redberg R, Gøtzsche PC, Lundh A. Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors. Bmj (Clinical Research Ed.). 363: k3654. PMID 30282703 DOI: 10.1136/Bmj.K3654 |
0.336 |
|
| 2018 |
Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive Care Medicine. PMID 30132025 DOI: 10.1007/S00134-018-5293-7 |
0.363 |
|
| 2018 |
Bero L. Ten tips for spotting industry involvement in science policy. Tobacco Control. PMID 29941543 DOI: 10.1136/Tobaccocontrol-2018-054386 |
0.354 |
|
| 2018 |
Rezende LFM, Rey-López JP, Sá TH, Chartres N, Fabbri A, Powell L, Stamatakis E, Bero L. Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality. Plos Biology. 16: e2005761. PMID 29912869 DOI: 10.1371/Journal.Pbio.2005761 |
0.34 |
|
| 2018 |
Wang Z, Norris SL, Bero L. The advantages and limitations of guideline adaptation frameworks. Implementation Science : Is. 13: 72. PMID 29843737 DOI: 10.1186/S13012-018-0763-4 |
0.344 |
|
| 2018 |
Mahmić-Kaknjo M, Jeličić-Kadić A, Utrobičić A, Chan K, Bero L, Marušić A. Essential medicines availability is still suboptimal in many countries: A scoping review. Journal of Clinical Epidemiology. PMID 29452222 DOI: 10.1016/J.Jclinepi.2018.02.006 |
0.352 |
|
| 2018 |
Blake P, Durão S, Naude CE, Bero L. An analysis of methods used to synthesize evidence and grade recommendations in food-based dietary guidelines. Nutrition Reviews. PMID 29425371 DOI: 10.1093/Nutrit/Nux074 |
0.361 |
|
| 2018 |
Grundy Q, Dunn AG, Bourgeois FT, Coiera E, Bero L. Prevalence of Disclosed Conflicts of Interest in Biomedical Research and Associations With Journal Impact Factors and Altmetric Scores. Jama. 319: 408-409. PMID 29362787 DOI: 10.1001/Jama.2017.20738 |
0.308 |
|
| 2017 |
Bero L. Getting the systematic review basics right helps clinical practice: 4 common pitfalls for systematic review authors to avoid. British Journal of Sports Medicine. PMID 29217534 DOI: 10.1136/Bjsports-2017-098239 |
0.37 |
|
| 2017 |
Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. The Cochrane Database of Systematic Reviews. 2: MR000033. PMID 28207928 DOI: 10.1002/14651858.Mr000033.Pub3 |
0.379 |
|
| 2016 |
Wang Z, Norris SL, Bero L. Implementation plans included in World Health Organisation guidelines. Implementation Science : Is. 11: 76. PMID 27207104 DOI: 10.1186/S13012-016-0440-4 |
0.337 |
|
| 2016 |
Johnson PI, Koustas E, Vesterinen HM, Sutton P, Atchley DS, Kim AN, Campbell M, Donald JM, Sen S, Bero L, Zeise L, Woodruff TJ. Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan. Environment International. PMID 27156197 DOI: 10.1016/J.Envint.2016.03.009 |
0.339 |
|
| 2016 |
Morgan RL, Thayer KA, Bero L, Bruce N, Falck-Ytter Y, Ghersi D, Guyatt G, Hooijmans C, Langendam M, Mandrioli D, Mustafa RA, Rehfuess EA, Rooney AA, Shea B, Silbergeld EK, et al. GRADE: Assessing the quality of evidence in environmental and occupational health. Environment International. PMID 26827182 DOI: 10.1016/J.Envint.2016.01.004 |
0.36 |
|
| 2016 |
Bero L, Anglemyer A, Vesterinen H, Krauth D. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis Environment International. 92: 597-604. PMID 26694022 DOI: 10.1016/J.Envint.2015.10.011 |
0.372 |
|
| 2015 |
Alexander PE, Gionfriddo MR, Li SA, Bero L, Stoltzfus RJ, Neumann I, Brito JP, Djulbegovic B, Montori VM, Norris SL, Schünemann HJ, Thabane L, Guyatt GH. A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance. Journal of Clinical Epidemiology. PMID 26399903 DOI: 10.1016/J.Jclinepi.2015.09.006 |
0.351 |
|
| 2015 |
Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K. Public Opinions about Overdiagnosis: A National Community Survey. Plos One. 10: e0125165. PMID 25992887 DOI: 10.1371/Journal.Pone.0125165 |
0.309 |
|
| 2015 |
Schroll JB, Bero L. Regulatory agencies hold the key to improving Cochrane reviews of drugs. The Cochrane Database of Systematic Reviews. 4: ED000098. PMID 25904511 DOI: 10.1002/14651858.Ed000098 |
0.32 |
|
| 2015 |
Anglemyer AT, Krauth D, Bero L. Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis. Bmc Medical Research Methodology. 15: 12. PMID 25880564 DOI: 10.1186/S12874-015-0008-Z |
0.375 |
|
| 2015 |
Siler K, Lee K, Bero L. Reply to Margalida and Colomer: Science should strive to prevent mistakes, not corrections. Proceedings of the National Academy of Sciences of the United States of America. 112: E1512. PMID 25759436 DOI: 10.1073/Pnas.1501371112 |
0.315 |
|
| 2015 |
Hill SR, Bero L, McColl G, Roughead E. Expensive medicines: ensuring objective appraisal and equitable access. Bulletin of the World Health Organization. 93: 4. PMID 25558099 DOI: 10.2471/Blt.14.148924 |
0.339 |
|
| 2015 |
Siler K, Lee K, Bero L. Measuring the effectiveness of scientific gatekeeping. Proceedings of the National Academy of Sciences of the United States of America. 112: 360-5. PMID 25535380 DOI: 10.1073/Pnas.1418218112 |
0.358 |
|
| 2015 |
Schroll JB, Abdel-Sattar M, Bero L. The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reports. Journal of Clinical Epidemiology. 68: 102-7. PMID 25150193 DOI: 10.1016/J.Jclinepi.2014.06.019 |
0.337 |
|
| 2015 |
Mahady SE, Schlub T, Bero L, Moher D, Tovey D, George J, Craig JC. Side effects are incompletely reported among systematic reviews in gastroenterology. Journal of Clinical Epidemiology. 68: 144-53. PMID 25124168 DOI: 10.1016/J.Jclinepi.2014.06.016 |
0.361 |
|
| 2014 |
Alexander PE, Brito JP, Neumann I, Gionfriddo MR, Bero L, Djulbegovic B, Stoltzfus R, Montori VM, Norris SL, Schünemann HJ, Guyatt GH. World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance. Journal of Clinical Epidemiology. PMID 25618534 DOI: 10.1016/J.Jclinepi.2014.10.011 |
0.364 |
|
| 2014 |
Bero L. Bias related to funding source in statin trials. Bmj (Clinical Research Ed.). 349: g5949. PMID 25281682 DOI: 10.1136/Bmj.G5949 |
0.332 |
|
| 2014 |
Fox DM, Bero L. Systematic reviews: perhaps "the answer to policy makers' prayers"? Environmental Health Perspectives. 122: A262-3. PMID 25272205 DOI: 10.1289/Ehp.1408599 |
0.41 |
|
| 2014 |
Magrini N, Robertson J, de Joncheere K, Bero L. On WHO's essential medicines process and transparency. Bmj (Clinical Research Ed.). 349: g5637. PMID 25231094 DOI: 10.1136/Bmj.G5637 |
0.35 |
|
| 2014 |
Bero L. What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines. Journal of Clinical Epidemiology. 67: 1239-41. PMID 25132356 DOI: 10.1016/J.Jclinepi.2014.06.015 |
0.399 |
|
| 2014 |
Tovey D, Churchill R, Bero L. Evidence based medicine: looking forward and building on what we have learnt. Bmj (Clinical Research Ed.). 349: g4508. PMID 25008476 DOI: 10.1136/Bmj.G4508 |
0.309 |
|
| 2014 |
Anglemyer A, Horvath HT, Bero L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. The Cochrane Database of Systematic Reviews. MR000034. PMID 24782322 DOI: 10.1002/14651858.Mr000034.Pub2 |
0.333 |
|
| 2014 |
Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environmental Health Perspectives. 122: A67. PMID 24583480 DOI: 10.1289/Ehp.1307727R |
0.392 |
|
| 2014 |
Krauth D, Anglemyer A, Philipps R, Bero L. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis. Plos Biology. 12: e1001770. PMID 24465178 DOI: 10.1371/Journal.Pbio.1001770 |
0.345 |
|
| 2014 |
Alexander PE, Bero L, Montori VM, Brito JP, Stoltzfus R, Djulbegovic B, Neumann I, Rave S, Guyatt G. World Health Organization recommendations are often strong based on low confidence in effect estimates. Journal of Clinical Epidemiology. 67: 629-34. PMID 24388966 DOI: 10.1016/J.Jclinepi.2013.09.020 |
0.301 |
|
| 2014 |
Mahady SE, Schlub TE, Bero L, George J, Craig J. Mo1105 Side Effects Are Side Issues: Completeness of Reporting of Harms Among Systematic Reviews in Gastroenterology Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)62020-5 |
0.332 |
|
| 2014 |
Steed L, Kassavou A, Madurasinghe VW, Edwards EA, Todd A, Summerbell CD, Nkansah N, Bero L, Durieux P, Taylor SJC, Rivas C, Walton RT. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. Cochrane Database of Systematic Reviews. 12. DOI: 10.1002/14651858.Cd011207 |
0.359 |
|
| 2013 |
Grundy Q, Bero L, Malone R. Interactions between non-physician clinicians and industry: a systematic review. Plos Medicine. 10: e1001561. PMID 24302892 DOI: 10.1371/Journal.Pmed.1001561 |
0.365 |
|
| 2013 |
Moynihan RN, Cooke GP, Doust JA, Bero L, Hill S, Glasziou PP. Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. Plos Medicine. 10: e1001500. PMID 23966841 DOI: 10.1371/Journal.Pmed.1001500 |
0.332 |
|
| 2013 |
Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environmental Health Perspectives. 121: 985-92. PMID 23771496 DOI: 10.1289/Ehp.1206389 |
0.32 |
|
| 2013 |
Wolfe N, Gøtzsche PC, Bero L. Strategies for obtaining unpublished drug trial data: a qualitative interview study. Systematic Reviews. 2: 31. PMID 23680054 DOI: 10.1186/2046-4053-2-31 |
0.352 |
|
| 2013 |
Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. The Cochrane Database of Systematic Reviews. 2: CD010398. PMID 23450614 DOI: 10.1002/14651858.Cd010398 |
0.327 |
|
| 2013 |
Conway J, Bero L, Ondari C, Wasan KM. Review of the quality of pediatric medications in developing countries. Journal of Pharmaceutical Sciences. 102: 1419-33. PMID 23450511 DOI: 10.1002/Jps.23474 |
0.316 |
|
| 2013 |
Bero L. Industry sponsorship and research outcome: a Cochrane review. Jama Internal Medicine. 173: 580-1. PMID 23440226 DOI: 10.1001/Jamainternmed.2013.4190 |
0.325 |
|
| 2013 |
Elias P, Norris S, Brito J, Stoltzfus R, Bero L, Djulbegovic B, Neumann I, Montiori V, Guyatt G. 075 The Use of GRADE Methods in the World Health Organization (Who) Public Health Guidelines (PHG): Distribution of Strength of Recommendations and Confidence in Estimates of Effect Bmj Quality & Safety. 22: A36.2-A36. DOI: 10.1136/Bmjqs-2013-002293.106 |
0.324 |
|
| 2012 |
Taba P, Rosenthal M, Habicht J, Tarien H, Mathiesen M, Hill S, Bero L. Barriers and facilitators to the implementation of clinical practice guidelines: A cross-sectional survey among physicians in Estonia Bmc Health Services Research. 12. PMID 23234504 DOI: 10.1186/1472-6963-12-455 |
0.352 |
|
| 2012 |
Hill S, Yang A, Bero L. Priority medicines for maternal and child health: a global survey of national essential medicines lists. Plos One. 7: e38055. PMID 22675435 DOI: 10.1371/Journal.Pone.0038055 |
0.342 |
|
| 2012 |
Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. Bmj (Clinical Research Ed.). 344: d7202. PMID 22214754 DOI: 10.1136/Bmj.D7202 |
0.347 |
|
| 2011 |
Smith R, Tovey D, Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Pais P. The Cochrane Library Oversight Committee. The Cochrane Database of Systematic Reviews. ED000021. PMID 21833980 DOI: 10.1002/14651858.Ed000021 |
0.386 |
|
| 2010 |
Bero L, Carson B, Moller H, Hill S. To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008. Bulletin of the World Health Organization. 88: 922-9. PMID 21124717 DOI: 10.2471/Blt.10.079764 |
0.308 |
|
| 2010 |
Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. The Cochrane Database of Systematic Reviews. CD000336. PMID 20614422 DOI: 10.1002/14651858.Cd000336.Pub2 |
0.339 |
|
| 2009 |
Rasmussen N, Lee K, Bero L. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials. 10: 116. PMID 20015404 DOI: 10.1186/1745-6215-10-116 |
0.327 |
|
| 2009 |
Robertson J, Moynihan R, Walkom E, Bero L, Henry D. Mandatory disclosure of pharmaceutical industry-funded events for health professionals. Plos Medicine. 6: e1000128. PMID 19885393 DOI: 10.1371/Journal.Pmed.1000128 |
0.359 |
|
| 2009 |
Rattinger G, Bero L. Factors associated with results and conclusions of trials of thiazolidinediones. Plos One. 4: e5826. PMID 19503811 DOI: 10.1371/Journal.Pone.0005826 |
0.309 |
|
| 2009 |
Nkansah N, Nguyen T, Iraninezhad H, Bero L. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Public Health Nutrition. 12: 1931-1937. PMID 19254426 DOI: 10.1017/S136898000900487X |
0.308 |
|
| 2008 |
Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. Plos Medicine. 5: 1561-1570. PMID 19067477 DOI: 10.1371/Journal.Pmed.0050217 |
0.328 |
|
| 2007 |
Finley PR, Bero L. Clarification of Study and Citation Jama Internal Medicine. 167: 2531-2531. PMID 18071185 DOI: 10.1001/Archinte.167.22.2531-A |
0.306 |
|
| 2007 |
White J, Parascandola M, Bero L. Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine & Tobacco Research. 9: 1213-1225. PMID 17978997 DOI: 10.1080/14622200701648425 |
0.315 |
|
| 2007 |
Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. Plos Medicine. 4. PMID 17550302 DOI: 10.1371/Journal.Pmed.0040184 |
0.329 |
|
| 2007 |
Jewell C, Bero L. Public participation and claimsmaking: Evidence utilization and divergent policy frames in California's ergonomics rulemaking Journal of Public Administration Research and Theory. 17: 625-650. DOI: 10.1093/Jopart/Mul023 |
0.341 |
|
| 2005 |
Baba A, Cook DM, McGarity TO, Bero LA. Legislating "sound science": the role of the tobacco industry. American Journal of Public Health. 95: S20-7. PMID 16030333 DOI: 10.2105/Ajph.2004.050963 |
0.332 |
|
| 2003 |
Bero L. Implications of the tobacco industry documents for public health and policy Annual Review of Public Health. 24: 267-288. PMID 12415145 DOI: 10.1146/Annurev.Publhealth.24.100901.140813 |
0.377 |
|
| 2001 |
Wenger L, Malone R, Bero L. The cigar revival and the popular press: a content analysis, 1987-1997. American Journal of Public Health. 91: 288-291. PMID 11211641 DOI: 10.2105/Ajph.91.2.288 |
0.359 |
|
| 2001 |
Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O’brien MA. Changing provider behavior: an overview of systematic reviews of interventions. Medical Care. 39: 2-45. DOI: 10.1097/00005650-200108002-00002 |
0.316 |
|
| 2000 |
Beney J, Bero L, Bond CM. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes Cochrane Database of Systematic Reviews. CD000336. PMID 10908471 DOI: 10.1002/14651858.Cd000336 |
0.321 |
|
| 2000 |
Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB. Coverage by the news media of the benefits and risks of medications New England Journal of Medicine. 342: 1645-1650. PMID 10833211 DOI: 10.1056/Nejm200006013422206 |
0.325 |
|
| 1997 |
Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. WITHDRAWN: Printed educational materials: effects on professional practice and health care outcomes. The Cochrane Database of Systematic Reviews. CD000172. PMID 17636612 DOI: 10.1002/14651858.Cd000172 |
0.333 |
|
| 1997 |
Granados A, Jonsson E, Banta HD, Bero L, Bonair A, Cochet C, Freemantle N, Grilli R, Grimshaw J, Harvey E, Levi R, Marshall D, Oxman A, Pasart L, Räisänen V, et al. EUR-ASSESS Project Subgroup Report on Dissemination and Impact. International Journal of Technology Assessment in Health Care. 13: 220-86. PMID 9194353 DOI: 10.1017/S0266462300010370 |
0.331 |
|
| 1997 |
Bero L. The electronic future: What might an online scientific paper look like in five years' time?: Length—and other strengths Bmj. 315: 1692-1692. DOI: 10.1136/Bmj.315.7123.1692 |
0.324 |
|
| 1995 |
Bero L, Barnes DE, Hanauer P, Glantz SA, Slade J. Lawyer Control of the Tobacco Industry's External Research Program: The Brown and Williamson Documents Jama: the Journal of the American Medical Association. 274: 241-247. PMID 7609233 DOI: 10.1001/Jama.1995.03530030061035 |
0.342 |
|
| 1995 |
Hanauer P, Barnes DE, Bero L, Glantz SA, Slade J. Lawyer Control of Internal Scientific Research to Protect Against Products Liability Lawsuits: The Brown and Williamson Documents Jama: the Journal of the American Medical Association. 274: 234-240. PMID 7609232 DOI: 10.1001/Jama.1995.03530030054034 |
0.319 |
|
| 1995 |
Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J. Looking Through a Keyhole at the Tobacco Industry: The Brown and Williamson Documents Jama: the Journal of the American Medical Association. 274: 219-224. PMID 7609230 DOI: 10.1001/Jama.1995.03530030039032 |
0.303 |
|
| 1995 |
Bero L, Rennie D. The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. Jama. 274: 1935-1938. DOI: 10.1001/Jama.1995.03530240045039 |
0.375 |
|
| Show low-probability matches. |